牙本质液炎症生物标志物用于牙髓炎分子诊断的探索
一项横断面 exploratory 研究纳入64例患者,按牙髓状态分为症状性不可复性牙髓炎(IP)23例、可复性牙髓炎(RP)20例和正常牙髓(NP)21例,从牙本质液中定量检测炎症生物标志物。结果显示IP与RP间IL-1α、VEGF-α和FGF酸水平差异显著,FGF酸和VEGF-α与IP诊断相关,含FGF酸、IL-1α、IL-6和TIMP-1的模型AUC-ROC达0.92。结论提示牙本质液可用于牙髓炎的分子诊断。
要点
- 牙本质液可检测牙髓炎症介质,辅助鉴别IP与RP。
- FGF酸和VEGF-α与IP诊断独立相关。
- FGF酸+IL-1α+IL-6+TIMP-1联合模型AUC达0.92。
核心结论
- 牙本质液可用于检测牙髓介质,实现牙髓炎的分子诊断。
- 尽管临床诊断存在局限性,仍可检测到症状性不可复性牙髓炎与可复性牙髓炎之间的差异,与联合标志物FGF酸+IL-6+IL-1α+TIMP-1相关。
研究设计与样本
- 横断面探索性研究,共招募64例患者。
- 按牙髓状态分组:IP组23例,RP组20例,NP组21例。
- 采用Luminex® MAGPIX平台系统与多重检测试剂盒定量生物标志物。
- 使用Kruskal-Wallis检验比较不同牙髓状态,简单逻辑回归模型计算OR及95%CI(P=0.05),通过ROC曲线及AUC评估判别性能,Youden标准确定截断点。
主要发现
- IP与RP相比,IL-1α、VEGF-α和FGF酸水平显著更高(P < 0.05)。
- FGF酸与IP versus RP的诊断相关(OR: 12.62; P = 0.0085; CI 95% 1.91-83.29)。
- VEGF-α与IP versus RP的诊断相关(OR: 2.61; P = 0.0252; CI 95% 1.13-6.03)。
- FGF酸的AUC-ROC曲线为0.79。
- 含FGF酸、IL-1α、IL-6和TIMP-1的模型AUC-ROC为0.92,与FGF酸ROC曲线差异显著(P = 0.0231)。
关键数值与推荐
- IP versus RP中FGF酸OR为12.62(P=0.0085,95%CI 1.91-83.29)。
- IP versus RP中VEGF-α OR为2.61(P=0.0252,95%CI 1.13-6.03)。
- FGF酸单独AUC-ROC为0.79;联合模型(FGF酸+IL-1α+IL-6+TIMP-1)AUC-ROC为0.92(P=0.0231 vs FGF酸)。
- 截断点仅对AUC > 70且P < 0.05的生物标志物或模型估计概率采用Youden标准确定。
临床怎么用
- 牙本质液采样可作为一种微创手段,辅助分子水平鉴别不可复性与可复性牙髓炎。
- FGF酸、VEGF-α及联合模型(FGF酸+IL-1α+IL-6+TIMP-1)具有潜在诊断价值,但需进一步验证。
局限性
- 本研究临床诊断方法存在局限性。
- 样本量有限(共64例),为横断面探索性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To explore a set of inflammatory biomarkers obtained from dentinal fluid (DF) from patients with symptomatic irreversible pulpitis (IP), reversible pulpitis (RP) and normal pulp (NP). METHODOLOGY: A cross-sectional exploratory study was performed, recruiting 64 patients on the basis of their respective pulp condition. DF samples were obtained from all patients (23, from IP patients; 20, from RP patients; and 21, from NP patients). Quantification of biomarkers was performed using a Luminex® MAGPIX platform system and multiplex assay kits. The Kruskal-Wallis test was used for comparisons with regard to pulp state. A simple logistic regression model and the odds ratio (OR) with a 95% level of confidence (P = 0.05) were used to evaluate associations between biomarker levels and pulpal diagnosis. The performance discrimination of the biomarkers was evaluated through the construction of a receiver operating characteristic (ROC) curve by calculating the area under the curve (AUC) for IP versus RP after logistic regression modelling. Youden criteria were used to establish cut-off points for biomarkers alone with AUC > 70 and P-value < 0.05, or estimated probabilities from the multivariable logistic model. RESULTS: The biomarkers that had significantly higher values in participants with IP versus RP were IL-1α, VEGF-α and FGF acid (P < 0.05). FGF acid (OR: 12.62; P = 0.0085; CI 95% 1.91-83.29) and VEGF-α (OR: 2.61; P = 0.0252; CI 95% 1.13-6.03) were associated with pulp diagnoses of IP versus RP. The AUC-ROC curve for FGF acid was 0.79. The model containing FGF acid, IL-1α, IL-6 and TIMP-1 had an AUC-ROC of 0.92 for IP versus RP with a significant difference from the FGF acid ROC curve (P = 0.0231). CONCLUSIONS: Dentinal fluid could be used to assay pulpal mediators in the molecular diagnosis of pulpitis. Despite the limitation of the clinical diagnostics used in the present study, it was possible to detect a difference between irreversible symptomatic pulpitis and reversible pulpitis associated with the following combined biomarkers: FGF acid + IL-6 + IL-1α, +TIMP-1.
引用
- Brizuela C, Meza G, Mercadé M, et al. Inflammatory biomarkers in dentinal fluid as an approach to molecular diagnostics in pulpitis. Int Endod J. 2020. PMID: 32496605. doi:10.1111/iej.13343
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。